申请人:MERCK PATENT GMBH
公开号:US20200317622A1
公开(公告)日:2020-10-08
The invention relates to pyrimidinone derivatives of the general Formula I,
or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.